WINNERS & LOSERS: Vanquis cuts outlook; Zoo Digital loss narrows
30th Jul 2026 11:20
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 5.25p on 14-08-2026 at 16:45:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 5.50p |
| Sell | 5.00p |
| Last Trade: | Unknown 160,000.00 at 5.40p |
| Day's Volume: | 195,702 |
| Last Close: | 5.25p |
| Open: | 5.25p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 5.25p - 5.50p |
| 52wk Range: | 5.00p - 12.10p |
| Market Capitalisation: | £332.46m |
| VWAP: | 5.404403p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 160,000 | 5.40p | Negotiated Trade |
15:53:44 - 14-Aug-26 |
| Buy* | 5,000 | 5.42p | Ordinary |
12:06:27 - 14-Aug-26 |
| Buy* | 18,467 | 5.415p | Ordinary |
10:28:55 - 14-Aug-26 |
| Buy* | 3,000 | 5.50p | Suspected BUY Trade |
09:00:25 - 14-Aug-26 |
| Buy* | 9,235 | 5.42p | Ordinary |
08:57:15 - 14-Aug-26 |
| Buy* | 64,000 | 5.418p | Ordinary |
15:35:53 - 13-Aug-26 |
| Buy* | 5,000 | 5.425p | Ordinary |
14:57:37 - 13-Aug-26 |
| Buy* | 5,000 | 5.425p | Ordinary |
14:54:03 - 13-Aug-26 |
| Buy* | 37,429 | 5.33p | Ordinary |
14:47:55 - 13-Aug-26 |
| Sell* | 37,986 | 5.24p | Ordinary |
14:25:59 - 13-Aug-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Jul 2026 7:00 am | RNS | Trading update for the year ended 30 June 2026 |
| 28th Jul 2026 7:00 am | RNS | Appointment of Executive Chairman |
| 30th Jun 2026 7:00 am | RNS | Vesting of Options under Long-Term Incentive Plan |
| 15th Jun 2026 7:00 am | RNS | Long Term Incentive Awards |
| 12th Jun 2026 7:00 am | RNS-R | Allergy Therapeutics to present at EAACI 2026 |
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |
| 26th Feb 2026 7:00 am | RNS-R | Allergy Therapeutics presents progress at AAAAI |